China will deliver an effective anti-virus medicine, Oseltamivir, to its provinces and autonomous regions, covering 2 percent of the population each, according to the Ministry of Health.

Xi Xiuming, an expert with the A/H1N1 expert board of the Ministry of Health, said: "Oseltamivir is imperative in battling A/H1N1, especially for severe cases," China National Radio reported.

Related

• A/H1N1 flu jabs: Shanghai sticks with game plan
• A/H1N1 vaccine safe for public: Authorities
• Beijing to extend vaccine inoculation amid rising death toll from A/H1N1 flu

Comments